Edition:
United Kingdom

Gensight Biologics SA (SIGHT.PA)

SIGHT.PA on Paris Stock Exchange

1.78EUR
11:45am GMT
Change (% chg)

€0.08 (+4.71%)
Prev Close
€1.70
Open
€1.64
Day's High
€1.80
Day's Low
€1.63
Volume
83,667
Avg. Vol
76,181
52-wk High
€7.68
52-wk Low
€1.34

Revenue & Earnings Per Share

    Revenue* Earnings Per Share**
FY 2018 Jun '18 0.00 -0.481
FY 2017 Dec '17 0.00 -0.507
Jun '17 0.00 -0.622
 
*Note: Units in Millions ofEuro
**Note: Units in Euro

Consensus Estimates Analysis

  # of Estimates Mean High Low 1 Year Ago
SALES (in millions)
Year Ending Dec-18 3 13.60 37.00 0.00 12.83
Year Ending Dec-19 3 3.63 7.00 0.00 32.17
Earnings (per share)
Year Ending Dec-18 3 -0.57 -0.07 -0.97 -0.79
Year Ending Dec-19 3 -0.90 -0.46 -1.15 -0.33
Sales and Profit Figures in Euro (EUR);

Valuation Ratios

  Company industry sector
P/E Ratio (TTM) -- 85.49 33.64
P/E High - Last 5 Yrs. -- 308.81 45.61
P/E Low - Last 5 Yrs. -- 85.16 23.70
Beta -- 0.93 0.88
Price to Sales (TTM) -- 121.71 5.95
Price to Book (MRQ) 1.81 14.77 4.89
Price to Tangible Book (MRQ) 1.86 13.90 6.50
Price to Cash Flow (TTM) -- 66.81 22.90
% Owned Institutions -- 13.77 2.15

Dividends

  Company industry sector
Dividend Yield -- 0.41 1.51
Dividend Yield - 5 Year Avg -- 0.31 1.52
Dividend 5 Year Growth Rate -- 2.84 5.41
Payout Ratio(TTM) -- 25.52 43.93

Growth Rates

  Company industry sector
Sales (MRQ) vs Qtr. 1 Yr. Ago -- 387.08 8.08
Sales (TTM) vs TTM 1 Yr. Ago -- 97.70 5.80
Sales - 5 Yr. Growth Rate -- 29.11 9.84
EPS (MRQ) vs Qtr. 1 Yr. Ago -- 27.93 23.27
EPS (TTM) vs TTM 1 Yr. Ago -- -- --
EPS - 5 Yr. Growth Rate -- 33.15 10.88
Capital Spending - 5 Yr. Growth Rate -- 36.76 14.85

Financial Strength

  Company industry sector
Quick Ratio (MRQ) -- 2.02 2.27
Current Ratio (MRQ) 14.47 5.29 3.07
LT Debt to Equity (MRQ) 4.08 36.70 13.15
Total Debt to Equity (MRQ) 4.08 38.52 17.74
Interest Coverage (TTM) -- -90.95 37.29

Profitability Ratios

  Company industry sector
Gross Margin (TTM) -- 40.04 54.86
Gross Margin - 5 Yr. Avg. -- 48.29 52.38
EBITD Margin (TTM) -- -- --
EBITD - 5 Yr. Avg -- -554.68 10.90
Operating Margin (TTM) -- -797.48 3.24
Operating Margin - 5 Yr. Avg. -- -575.66 6.22
Pre-Tax Margin (TTM) -- -760.61 4.31
Pre-Tax Margin - 5 Yr. Avg. -- -581.06 6.66
Net Profit Margin (TTM) -- -761.46 0.58
Net Profit Margin - 5 Yr. Avg. -- -583.69 2.90
Effective Tax Rate (TTM) -- 25.03 23.26
Effective Tax Rate - 5 Yr. Avg. -- 19.86 24.21

Efficiency

  Company industry sector
Revenue/Employee (TTM) -- 22,793,236 803,317,434
Net Income/Employee (TTM) -- 1,402,790 94,479,245
Receivable Turnover (TTM) -- 19.90 5.78
Inventory Turnover (TTM) -- 2.68 3.71
Asset Turnover (TTM) -- 0.42 0.92

Management Effectiveness

  Company industry sector
Return on Assets (TTM) -- -1.66 10.86
Return on Assets - 5 Yr. Avg. -- 2.77 11.96
Return on Investment (TTM) -- -0.29 14.22
Return on Investment - 5 Yr. Avg. -- 1.51 15.54
Return on Equity (TTM) -- 0.40 15.99
Return on Equity - 5 Yr. Avg. -- 1.96 16.82
  1 Year 3 Year 5 Year
Sales % -- -- --
EPS (TTM) % -11.84 -- --
Dividend % -- -- --
Note: Units in Millions of US Dollars

Performance for Gensight Biologics SA

Period %
Actual
% vs.
S&P 500
Rank In
Industry
Industry
Rank
4 Week 2.40 -2.30 99 58
13 Week 6.24 1.98 99 61
26 Week -29.22 -32.19 45 74
52 Week -39.53 -49.45 46 45
YTD -34.06 -40.19 40 55
Note:: Rank is a percentile that ranges from 0 to 99, with 99 = best.

Institutional Holders

% Shares Owned: 45.70%
# of Holders: 11
Total Shares Held: 11,317,875
3 Mo. Net Change: -874,973
# New Positions: 0
# Closed Positions: 0
# Increased Positions: 1
# Reduced Positions: 2
# Net Buyers: -1
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.